Melanie R. Shakespear
- Immunology top 10%
- Immune cells in cancer 3
- IL-33, ST2, and ILC Pathways 1
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research 5
- Protein Degradation and Inhibitors 2
- Epigenetics and DNA Methylation 2
- Signaling Pathways in Disease 1
- Physiology top 5%
- Geriatrics and Gerontology top 10%
-
- Peptidase Inhibition and Analysis 3
-
- Autophagy in Disease and Therapy 1
Melanie R. Shakespear
7 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 91
- Immunology 362
- Molecular Biology 794
- Physiology 51
- Geriatrics and Gerontology 40
- Biological Psychiatry 21
Countries citing papers authored by Melanie R. Shakespear
This map shows the geographic impact of Melanie R. Shakespear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie R. Shakespear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie R. Shakespear more than expected).
Fields of papers citing papers by Melanie R. Shakespear
This network shows the impact of papers produced by Melanie R. Shakespear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie R. Shakespear. The network helps show where Melanie R. Shakespear may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Melanie R. Shakespear, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 243 | |
| 2 | 2018 | 57 | |
| 3 | 2016 | 99 | |
| 4 | 2015 | 39 | |
| 5 | 2013 | 84 | |
| 6 | 2011 | 64 | |
| 7 | 2011 | 432 |
About Melanie R. Shakespear
Melanie R. Shakespear is a scholar working on Biological Psychiatry, Immunology and Oncology, having authored 7 papers that have together received 1.0k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (5 papers), Peptidase Inhibition and Analysis (3 papers), Immune cells in cancer (3 papers), Protein Degradation and Inhibitors (2 papers), Epigenetics and DNA Methylation (2 papers), IL-33, ST2, and ILC Pathways (1 paper), Autophagy in Disease and Therapy (1 paper) and Signaling Pathways in Disease (1 paper). The work is most often cited by research in Immunology (362 citations), Molecular Biology (794 citations) and Physiology (51 citations). Melanie R. Shakespear has collaborated with scholars based in Australia, India and Germany. Frequent co-authors include Matthew J. Sweet, David P. Fairlie, Katharine M. Irvine, Maria A. Halili, Abishek Iyer, Kaustav Das Gupta, Kate Schroder, Kaiwen Chen, Darren L. Brown and Jessica B. von Pein. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.